Investors with a lot of money to spend have taken a bullish stance on DexCom DXCM.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with DXCM, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 10 options trades for DexCom.
This isn't normal.
The overall sentiment of these big-money traders is split between 80% bullish and 10%, bearish.
Out of all of the options we uncovered, 9 are puts, for a total amount of $403,590, and there was 1 call, for a total amount of $28,000.
Predicted Price Range
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $45.0 to $80.0 for DexCom over the last 3 months.
Volume & Open Interest Development
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in DexCom's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to DexCom's substantial trades, within a strike price spectrum from $45.0 to $80.0 over the preceding 30 days.
DexCom Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
DXCM | PUT | SWEEP | BEARISH | 01/16/26 | $18.0 | $17.7 | $18.0 | $75.00 | $117.0K | 246 | 66 |
DXCM | PUT | TRADE | BULLISH | 09/19/25 | $3.8 | $3.6 | $3.6 | $45.00 | $54.0K | 4 | 150 |
DXCM | PUT | SWEEP | BULLISH | 01/17/25 | $14.9 | $14.8 | $14.8 | $80.00 | $39.9K | 2.6K | 27 |
DXCM | PUT | SWEEP | BULLISH | 01/17/25 | $14.8 | $14.6 | $14.6 | $80.00 | $36.5K | 2.6K | 52 |
DXCM | PUT | SWEEP | BULLISH | 09/19/25 | $13.8 | $13.8 | $13.8 | $70.00 | $35.8K | 2 | 47 |
About DexCom
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Having examined the options trading patterns of DexCom, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
DexCom's Current Market Status
- Trading volume stands at 1,519,451, with DXCM's price up by 0.82%, positioned at $68.67.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 17 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DexCom options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.